Search Results

Penumbra Appoints Dr. Donald Frei as Associate Chief Medical Officer of Neuro

August 11, 2026—Penumbra announced today that Donald Frei, MD, will serve as Associate Chief Medical Officer of Neuro.

Society of NeuroInterventional Surgery Launches “Get Ahead of Stroke” Campaign

May 25, 2016—The Society of NeuroInterventional Surgery (SNIS) announced a new initiative, the “Get Ahead of Stroke” national public education and advocacy campaign designed to improve systems of care for stroke patients.

Penumbra 3D Stent Retriever Plus Aspiration Trial Meets Primary Endpoints

July 27, 2016—Penumbra, Inc. announced that its 3D stent retriever revascularization device used in conjunction with Penumbra aspiration devices demonstrated noninferior safety and efficacy compared to using Penumbra system aspiration devices alone, meeting the primary endpoints set in the Penumbra 3D trial.

Neurointerventional Training Guidelines Aim to Ensure Optimal Outcomes for Ischemic Stroke Patients

February 24, 2016—The Society of NeuroInterventional Surgery (SNIS) recently announced the release of new multisociety training guidelines for endovascular intervention in ischemic stroke patients.

Standardized Protocol Studied for Timely Treatment of ELVO Stroke Patients

July 24, 2018—Findings from a study presented at the Society of NeuroInterventional Surgery’s (SNIS) 15th Annual Meeting held July 23–26 in San Francisco, California, demonstrated that developing a standardized stroke protocol of neurointerventional teams meeting suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of < 60 minutes.

Penumbra’s Thunderbolt CAVT Platform Cleared by FDA for Stroke Treatment

June 11, 2026—Penumbra, Inc. announced it has received FDA clearance for the Thunderbolt computer-assisted vacuum thrombectomy (CAVT) platform for the treatment of acute ischemic stroke.

Penumbra’s Red 72 Silver Label Reperfusion Catheters Receive CE Mark Approval for Acute Ischemic Stroke

June 30, 2026—Penumbra Inc. announced it has received CE Mark approval for its Red 72 Silver Label and Red 72 Silver Label with SendIt technology.

Societies Respond to Publication of MR CLEAN Trial Data

December 17, 2014—The Society of Neurointerventional Surgery (SNIS) and the European Society of Minimally Invasive Neurological Therapy (ESMINT) have commented on the publication of the MR CLEAN study online in The New England Journal of Medicine, which demonstrated that the addition of intra-arterial clot removal is more effective than intravenous-administered tissue plasminogen activator (IV-tPA, alteplase) therapy alone for the treatment of stroke. On December 22, leaders of the Society of Vascular & Interventional Neurology (SVIN) issued a statement on the MR CLEAN data.

THUNDER Results Presented for Penumbra’s Thunderbolt CAVT System in Stroke Patients

July 22, 2026—Penumbra, Inc. announced the results of the THUNDER investigational device exemption (IDE) study evaluating the safety and effectiveness of the company’s Thunderbolt computer assisted vacuum thrombectomy (CAVT) system in stroke patients with emergent large vessel occlusion (ELVO). The single-arm, prospective, multicenter study used core-lab adjudication and enrolled 216 patients across 29 centers in the United States.

STRATIS Registry Evaluates Efficiency in Stroke Treatment; SNIS Aims to "Get Ahead of Stroke"

July 27, 2016—Findings from the STRATIS registry presented at the Society of NeuroInterventional Surgery's (SNIS) 13th Annual Meeting in Boston, Massachusetts, found that stroke patients who go directly to an endovascular center could potentially receive treatment 99 minutes earlier.

Codman Neuro Launches Codman Enterprise 2 to Treat Wide-Necked Intracranial Aneurysms

February 16, 2016—Codman Neuro, part of the DePuy Synthes Companies of Johnson & Johnson, announced the launch of the Codman Enterprise 2 vascular reconstruction device, the latest generation of the company’s self-expanding stent and delivery system used to treat wide-necked intracranial aneurysms and to help maintain the position of endovascular coils during and after the procedure.

New Generations of Devices Improving Treatment Outcomes for Stroke

July 27, 2015—The Society of NeuroInterventional Surgery (SNIS) announced that two new studies released at the SNIS 12th annual meeting in San Francisco, California, reinforce the value and progress of intra-arterial treatment for stroke.

STRATIS Registry Evaluates Effects of Interhospital Transfer on Stroke Patients Before Thrombectomy

December 13, 2017—Findings from the STRATIS registry were published by Michael T. Froehler, MD, et al in Circulation (2017;136:2311–2321). STRATIS (Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke) was a prospective, multicenter, observational, single-arm study of real-world mechanical thrombectomy for acute stroke due to anterior circulation large vessel occlusion.